DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

Sector

Healthcare Facilities & Services

More about the company

Real-time Estimate Tradegate Other stock markets 08:01:39 18/06/2026 pm IST			5-day change	1st Jan Change
11.85 ^EUR	0.00%		0.00%	-

17/04	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
09/04	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	6.09Cr 7.06Cr 5.6Cr 5.27Cr 9.9Cr 666.05Cr 9.98Cr 66Cr 26Cr 326.89Cr 26Cr 26Cr 1.13TCr	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	4.33Cr 5.02Cr 3.98Cr 3.75Cr 7.04Cr 473.63Cr 7.1Cr 47Cr 18Cr 232.45Cr 19Cr 18Cr 804.15Cr	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

17/04	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
09/04	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/25/30	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
16/25/16	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
10/25/10	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/24/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/24/11	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/23/30	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
14/23/14	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/22/30	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
15/22/15	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
29/21/29	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
16/21/16	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

16/04	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/25/15	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/23/04	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
30/20/30	DocCheck AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
30/20/30	DGAP-NVR : DocCheck AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	DJ

DocCheck AG Share Price BOERSE BERLIN

Stocks

ANWGn

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Managers and Directors: DocCheck AG

Other Healthcare Facilities & Services

Financials

Company Profile

28/05	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
28/05	DocCheck : Nachtrag (AJ91 1 Nachtrag)
25/05	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
20/05	Vorläufige Zahlen zum ersten Quartal 2026
07/05	DocCheck : Jahresabschluss für das Geschäftsjahr 2025 und Lagebericht (DocCheck AG Einzelabschluss 31.12.2025 2)

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	01/08/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	01/08/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	15/12/2014
Winfried Leimeister BRD	Director/Board Member	-	01/01/1999
Karin Immenroth BRD	Director/Board Member	-	31/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	0.00%	0.00%	-	-	7.06Cr
CVS HEALTH CORPORATION	-0.42%	-2.22%	+46.99%	+43.08%	13TCr
HCA HEALTHCARE, INC.	-2.19%	+0.39%	+0.83%	+33.19%	8.61TCr
FRESENIUS SE & CO. KGAA	+0.32%	+4.86%	-7.09%	+53.24%	2.55TCr
QUEST DIAGNOSTICS INCORPORATED	-2.28%	-4.82%	+7.91%	+40.54%	2.19TCr
LABCORP HOLDINGS INC.	-1.87%	-3.92%	-2.49%	+10.11%	2.13TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.05%	+2.59%	-9.12%	-22.77%	2.03TCr
TENET HEALTHCARE CORPORATION	-1.78%	+1.65%	+5.04%	+124.52%	1.54TCr
REDE D'OR SÃO LUIZ S.A.	+0.72%	-1.97%	-5.39%	-0.24%	1.44TCr
DAVITA INC.	-1.42%	+2.32%	+53.58%	+113.00%	1.35TCr
Average	-0.88%	+2.25%	+10.03%	+43.85%	3.83TCr
Weighted average by Cap.	-1.05%	+2.07%	+18.83%	+39.85%

	2024	2025
Net sales	5.38Cr 6.23Cr 4.94Cr 4.65Cr 8.75Cr 588.38Cr 8.82Cr 59Cr 23Cr 288.77Cr 23Cr 23Cr 998.97Cr	5.53Cr 6.41Cr 5.09Cr 4.79Cr 8.99Cr 605.12Cr 9.07Cr 60Cr 23Cr 296.98Cr 24Cr 24Cr 1.03TCr
Net income	52.83L 61.24L 48.57L 45.72L 85.91L 58Cr 86.63L 5.76Cr 2.24Cr 28Cr 2.3Cr 2.25Cr 98Cr	53.34L 61.83L 49.04L 46.16L 86.74L 58Cr 87.47L 5.81Cr 2.26Cr 29Cr 2.32Cr 2.27Cr 99Cr
Net Debt	-2.01Cr -2.33Cr -1.85Cr -1.74Cr -3.27Cr -219.97Cr -3.3Cr -22Cr -8.53Cr -107.96Cr -8.75Cr -8.56Cr -373.47Cr	-1.76Cr -2.04Cr -1.62Cr -1.52Cr -2.86Cr -192.42Cr -2.88Cr -19Cr -7.46Cr -94Cr -7.65Cr -7.49Cr -326.69Cr